DOW JONES22,126.27+489.49 2.26%
S&P 5002,607.14+65.67 2.58%
NASDAQ7,730.22+227.84 3.04%

Regulus Therapeutics Q4 EPS $(0.23) Up From $(0.98) YoY

Regulus Therapeutics (NASDAQ:RGLS) reported quarterly losses of $(0.23) per share. This is a 76.53 percent increase over losses of $(0.98) per share from the same period last year.

Benzinga · 03/12/2020 20:37

Regulus Therapeutics (NASDAQ:RGLS) reported quarterly losses of $(0.23) per share. This is a 76.53 percent increase over losses of $(0.98) per share from the same period last year.